Antria, Inc.
Pioneering the future of regenerative medicine and cellular therapies across a wide expanse of medical specialties.
Pioneering the future of regenerative medicine and cellular therapies across a wide expanse of medical specialties.
Antria, Inc. is a biotechnology startup founded in 2011 that focuses on pioneering the future of regenerative medicine and cellular therapies across various medical specialties. The company specializes in the development of innovative cellular therapies for cosmetic applications, chronic medical conditions, and diseases impacting millions of patients globally. With a $1.44M Venture Round investment on 29 January 2013, it continues to make strides in the biotechnology and healthcare industries, attracting attention from potential investors. Antria, Inc. is poised to make significant contributions to the advancement of medical treatments and is a promising prospect for venture capital investment.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $1.44M | - | 29 Jan 2013 |
No recent news or press coverage available for Antria, Inc..
We care about your data, and we'd love to use cookies make your experience better.
